Search

Author/Creator Gilbert, L

1. 949PMirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), with pembrolizumab in platinum-resistant ovarian cancer (PROC): Initial results of an expansion cohort from FORWARD II, a phase Ib study. (23rd October 2018)

Authors:
Matulonis, U A; Moore, K N; Martin, L P; Vergote, I B; Castro, C; Gilbert, L; Malek, K; Birrer, M J; O'Malley, D M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. No diagnostic utility of antibody patterns against Klebsiella pneumoniae capsular serotypes in patients with axial spondyloarthritis vs. patients with non-specific low back pain: a cross-sectional study. (4th July 2017)

Authors:
Hermansen, LT; Loft, AG; Christiansen, AA; Munk, HL; Gilbert, L; Jurik, AG; Arnbak, B; Manniche, C; Weber, U; Østergaard, M; Pedersen, SJ; Barington, T; Junker, P; Hørslev-Petersen, K; Hendricks, O
Journal:
Scandinavian journal of rheumatology
Issue:
Volume 46:Number 4(2017)
Page Start:
296
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗